[Thrombosis].
Córdova
S
S
Dorantes-Mesa
S
S
Pizzuto
J
J
Ruiz-Argüelles
G
G
Izaguirre-Avila
R A
RA
D000925:Anticoagulants / Q000627:therapeutic use; D000990:Antithrombin III / Q000502:physiology; D020152:Antithrombin III Deficiency; D001777:Blood Coagulation / Q000502:physiology; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006023:Glycoproteins / Q000172:deficiency / Q000502:physiology; D006493:Heparin / Q000502:physiology / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011486:Protein C / Q000502:physiology; D020151:Protein C Deficiency; D017293:Protein S; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D006023:Glycoproteins; D010975:Platelet Aggregation Inhibitors; D011486:Protein C; D017293:Protein S; D000990:Antithrombin III; D006493:Heparin
Trombosis.